368 related articles for article (PubMed ID: 31070015)
1. Targeted fetal cell-free DNA screening for aneuploidies in 4,594 pregnancies: Single center study.
Koc A; Ozer Kaya O; Ozyilmaz B; Kutbay YB; Kirbiyik O; Ozdemir TR; Erdogan KM; Saka Guvenc M; Oztekin DC; Ozeren M; Pala HG; Ekin A; Gezer C; Sahingoz Yildirim AG; Konuralp Atakul B; Kurtulmus S; Turhan U; Taner CE
Mol Genet Genomic Med; 2019 Jul; 7(7):e00678. PubMed ID: 31070015
[TBL] [Abstract][Full Text] [Related]
2. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
[TBL] [Abstract][Full Text] [Related]
3. Cell-free DNA screening for aneuploidies in 7113 pregnancies: single Italian centre study.
Mesoraca A; Margiotti K; Dello Russo C; Cesta A; Cima A; Longo SA; Barone MA; Viola A; Sparacino D; Giorlandino C
Genet Res (Camb); 2020 Jun; 102():e5. PubMed ID: 32539871
[TBL] [Abstract][Full Text] [Related]
4. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions/microduplications in a cohort of 8141 single pregnancies.
Hu H; Wang L; Wu J; Zhou P; Fu J; Sun J; Cai W; Liu H; Yang Y
Hum Genomics; 2019 Mar; 13(1):14. PubMed ID: 30871627
[TBL] [Abstract][Full Text] [Related]
6. Assessment and Clinical Utility of a Non-Next-Generation Sequencing-Based Non-Invasive Prenatal Testing Technology.
Gormus U; Chaubey A; Shenoy S; Wong YW; Chan LY; Choo BP; Oraha L; Gousseva A; Persson F; Prensky L; Chin E; Hegde M
Curr Issues Mol Biol; 2021 Aug; 43(2):958-964. PubMed ID: 34449543
[No Abstract] [Full Text] [Related]
7. Performance of semiconductor sequencing platform for non-invasive prenatal genetic screening for fetal aneuploidy: results from a multicenter prospective cohort study in a clinical setting.
El Khattabi LA; Brun S; Gueguen P; Chatron N; Guichoux E; Schutz S; Nectoux J; Sorlin A; Quere M; Boudjarane J; Tsatsaris V; Mandelbrot L; Schluth-Bolard C; Dupont JM; Rooryck C;
Ultrasound Obstet Gynecol; 2019 Aug; 54(2):246-254. PubMed ID: 30191619
[TBL] [Abstract][Full Text] [Related]
8. Screening of fetal chromosomal aneuploidy diseases using noninvasive prenatal testing in twin pregnancies.
Yu W; Lv Y; Yin S; Liu H; Li X; Liang B; Kong L; Liu C
Expert Rev Mol Diagn; 2019 Feb; 19(2):189-196. PubMed ID: 30582381
[TBL] [Abstract][Full Text] [Related]
9. Clinical Validation of Non-Invasive Prenatal Testing for Fetal Common Aneuploidies in 1,055 Korean Pregnant Women: a Single Center Experience.
Lee DE; Kim H; Park J; Yun T; Park DY; Kim M; Ryu HM
J Korean Med Sci; 2019 Jun; 34(24):e172. PubMed ID: 31222985
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive Detection of Fetal Aneuploidy Using Next Generation Sequencing.
Curnow KJ; Sanderson RK; Beruti S
Methods Mol Biol; 2019; 1885():325-345. PubMed ID: 30506208
[TBL] [Abstract][Full Text] [Related]
11. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
[TBL] [Abstract][Full Text] [Related]
12. Analysis of cell-free DNA in a consecutive series of 13,607 routine cases for the detection of fetal chromosomal aneuploidies in a single center in Germany.
Borth H; Teubert A; Glaubitz R; Knippenberg S; Kutur N; Winkler T; Eiben B
Arch Gynecol Obstet; 2021 Jun; 303(6):1407-1414. PubMed ID: 33151425
[TBL] [Abstract][Full Text] [Related]
13. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
14. Performance of cell-free DNA testing for common fetal trisomies in triplet pregnancies.
Zakaria H; Kleinfinger P; Lohmann L; Costa JM; Tsatsaris V; Salomon LJ; Jouannic JM; Rosenblatt J; Demain A; Benachi A; El Khattabi L; Vivanti AJ
Prenat Diagn; 2024 May; 44(5):555-561. PubMed ID: 38448008
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive prenatal testing.
Lo JO; Cori D F; Norton ME; Caughey AB
Obstet Gynecol Surv; 2014 Feb; 69(2):89-99. PubMed ID: 25112487
[TBL] [Abstract][Full Text] [Related]
16. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
18. Contingent first-trimester screening for aneuploidies with cell-free DNA in a Danish clinical setting.
Miltoft CB; Rode L; Ekelund CK; Sundberg K; Kjaergaard S; Zingenberg H; Tabor A
Ultrasound Obstet Gynecol; 2018 Apr; 51(4):470-479. PubMed ID: 28640470
[TBL] [Abstract][Full Text] [Related]
19. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
[TBL] [Abstract][Full Text] [Related]
20. Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing.
Gordevičius J; Narmontė M; Gibas P; Kvederavičiūtė K; Tomkutė V; Paluoja P; Krjutškov K; Salumets A; Kriukienė E
Clin Epigenetics; 2020 Oct; 12(1):153. PubMed ID: 33081811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]